Tackling the blind spot of poor-quality medicines in Universal Health Coverage

BACKGROUND: Universal Health Coverage (UHC) is challenged by the prevalence of poor-quality medicines, those that either do not meet required specifications (substandard) or are outrightly fraudulent (falsified), especially in Low- and Middle-Income Countries, LMICs. Whereas poor-quality medicines a...

Descripción completa

Detalles Bibliográficos
Autores principales: Orubu, E. S. F., Ching, C., Zaman, M. H., Wirtz, V. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350647/
https://www.ncbi.nlm.nih.gov/pubmed/32670594
http://dx.doi.org/10.1186/s40545-020-00208-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350647/
https://www.ncbi.nlm.nih.gov/pubmed/32670594
http://dx.doi.org/10.1186/s40545-020-00208-4

Ejemplares similares